Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0001124524

CYRX

Cryoport, Inc.
$17.43 ▲ +0.40%
Prev close $17.36
Market cap$881.3M
ConsensusStrong Buy
12-mo target$19.67 (+12.8%)
▲ Bullish
Analyst conviction 9/10
Insider Selling Cluster (3 insiders)17 New Institutional Positions9 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on CYRX right now — valuation, ownership and activity at a glance.
Market Cap
$881.3M
Cap Size
Small Cap
Analyst Consensus
Strong Buy (88%)
Inst. Holders
50 funds
Inst. Value
$508.6M
Inst. Activity
17 buys / 9 sells
Insider Activity
$0.00 buy / $4.5M sell
Insider Net $
-$4.5M
SEC Reports
5
Price chart 30d +9.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 14, 2026 SEC
Six institutional investors accumulated $42.8M in Cryoport (CYRX) during 2026-Q2, led by First Eagle Investment Manageme
INST-CLUSTER — Impact 5/10
Aug 11, 2026 Insider
SHELTON JERRELL sold 28,800 shares
President, CEO @ $14.91 ($429.4K)
Aug 6, 2026 earnings_calendar
CYRX Q2 2026 Earnings After Market Close — 2026-08-06
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
2,276,741 shares ($35.7M)
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — TRIM
1,724,726 shares ($27.1M)
Jun 21, 2026 SEC
Institutional activity in CYRX during 2026-Q1 was mixed: 7 buyers accumulated $5.7M in new positions (led by First Eagle
INST-CLUSTER — Impact 4/10
Jun 12, 2026 SEC
Two CYRX insiders (CFO and a Director) sold a combined ~$3.12M in open-market shares over a 7-day window, representing ~
CLUSTER — Impact 4/10
Jun 11, 2026 Insider
ZECCHINI EDWARD J acquired via exercise 33,600 shares
Chief Digital and Tech Officer @ $4.80 ($161.3K)
Analyst ratings buy % +1.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Strong Buy 88% rate it Buy or better · 16 analysts
Strong Buy 6 38% Buy 8 50% Hold 2 13% Sell 0 0% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Oct 1, 2026GuggenheimMAINTAINBuy 52%
Sep 18, 2026BTIGREITERATEBuy 53%
Aug 7, 2026GuggenheimMAINTAINBuy 52%
Aug 7, 2026NeedhamMAINTAINBuy 50%
Jul 24, 2026BTIGMAINTAINBuy 53%
Jun 3, 2026Craig-HallumMAINTAINBuy 54%
May 20, 2026KeybancMAINTAINOverweight 52%
May 5, 2026GuggenheimMAINTAINBuy 52%
May 5, 2026NeedhamMAINTAINBuy 50%
May 5, 2026BTIGMAINTAINBuy 53%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20266820088%
Aug 1, 20266820088%
Jul 1, 20266820088%
Jun 1, 20266820088%
May 1, 20266820088%
Apr 1, 20266820088%
Mar 1, 20266720087%
Feb 1, 20266720087%
Price targets
Where 9 covering analysts think CYRX trades over the next 12 months.
$19.67 +12.8% upside Buy
Current$17.43 Low$15.00 Median$20.00 High$25.00 9 analysts
$15.00$25.00
Analyst rating Strong Buy· 1.3/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 3 neutral · avg impact 4.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 6, 2026
earnings_calendar
CYRX Q2 2026 Earnings After Market Close — 2026-08-06
May 4, 2026
earnings_calendar
CYRX Q1 2026 Earnings After Market Close — 2026-05-04
Mar 3, 2026
earnings_calendar
CYRX Q4 2025 Earnings After Market Close — 2026-03-03
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$-0.17$-0.18–$-0.17-30.5%+0.0%0↑ 1↓$0.0B3
Next Q$-0.17$-0.17–$-0.170.7%+0.0%0↑ 1↓$0.1B3
Current FY$-0.77$-0.81–$-0.71-13.5%+0.0%1↑ 1↓$0.2B3
Next FY$-0.66$-0.77–$-0.5713.9%+0.0%1↑ 0↓$0.2B3
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$-0.173—
7d ago$-0.173—
30d ago$-0.173—
60d ago$-0.163-0.010
90d ago$-0.163-0.010
Institutional ownership
Which big funds own CYRX (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $508.6M total value (32,385,025 shares) as of 2026-Q2. Top holders: BlackRock,, MORGAN, VANGUARD. Net buying activity: 17 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.4,218,434$66.2M13.0%—
MORGAN STANLEY2,276,741$35.7M7.0%TRIM -50.3%
VANGUARD CAPITAL MANAGEMENT LLC2,151,943$33.8M6.6%—
MILLENNIUM MANAGEMENT LLC1,724,726$27.1M5.3%TRIM -41.9%
FRED ALGER MANAGEMENT, LLC1,545,293$24.3M4.8%—
SUSQUEHANNA INTERNATIONAL GROUP, LLP1,482,500$23.3M4.6%—
GEODE CAPITAL MANAGEMENT, LLC1,312,370$20.6M4.1%—
First Eagle Investment Management, LLC1,271,424$20.0M3.9%ADD +70.7%
Assenagon Asset Management S.A.1,152,311$18.1M3.6%—
STATE STREET CORP1,046,875$16.4M3.2%—
Recent position changes
FundActionPrevCurrentChangeValue
MORGAN STANLEYTRIM4,576,7302,276,741-50.3%$35.7M
MILLENNIUM MANAGEMENT LLCTRIM2,970,4641,724,726-41.9%$27.1M
First Eagle Investment Management, LLCADD744,8491,271,424+70.7%$20.0M
Nuveen, LLCDOUBLED100,616922,935+817.3%$14.5M
DEUTSCHE BANK AG\TRIM1,000,676654,889-34.6%$10.3M
BNP Paribas Asset Management Holding S.A.TRIM778,361575,364-26.1%$9.0M
D. E. Shaw & Co., Inc.DOUBLED158,225479,625+203.1%$7.5M
JANE STREET GROUP, LLCADD292,654455,203+55.5%$7.1M
Squarepoint Ops LLCDOUBLED46,927368,424+685.1%$5.8M
Qube Research & Technologies LtdDOUBLED47,490358,008+653.9%$5.6M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 34 transactions. Net -$4.5M — $0.00 bought, $4.5M sold.
DateInsiderTitleTypeSharesPriceValue
Aug 11, 2026SHELTON JERRELLPresident, CEOSELL28,800$14.91$429.4K
Jun 11, 2026ZECCHINI EDWARD JChief Digital and Tech OfficerEXERCISE33,600$4.80$161.3K
Jun 11, 2026ZECCHINI EDWARD JChief Digital and Tech OfficerSELL33,600$14.47$486.2K
Jun 10, 2026ZECCHINI EDWARD JChief Digital and Tech OfficerEXERCISE1,400$4.80$6.7K
Jun 10, 2026ZECCHINI EDWARD JChief Digital and Tech OfficerSELL1,400$15.23$21.3K
Jun 8, 2026Mandalam RamkumarDirectorSELL23,214$15.44$358.5K
Jun 5, 2026HANCOCK DANIEL MDirectorAWARD10,350——
Jun 5, 2026Hariri Robert JDirectorAWARD16,077——
Jun 5, 2026Hariri Robert JDirectorAWARD10,350——
Jun 5, 2026HANCOCK DANIEL MDirectorAWARD16,077——
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CYRX.
Shares short
2,786,514
Settlement Sep 15, 2026
Change vs prior
+2.7%
Semi-monthly cycle
Days to cover
5.8
At avg daily volume
Of shares outstanding
≈5.5%
Estimate — not % of float
All CYRX filing & press-release reports (5)